( 1 H-NMR, 500 MHz
Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine [press release]
Together, they support the physical and mental stamina needed to lose weight safely and sustainably
[ 4 ] However, enthusiasm surrounding DSIP was shaken due to difficulties replicating the original findings
Thyroid issuesmost commonly hypothyroidism, hyperthyroidism, and, less frequently, thyroid stormare the most commonly reported endocrine toxicity following ICI medication in clinical trials (Barroso-Sousa et al
Official Answer by Drugs.com The most effective GLP-1 drug for weight loss currently (as of early 2026) is tirzepatide, marketed under the names Zepbound (for weight loss) and Mounjaro (for diabetes)